NewLink Genetics Reports Second Quarter 2016 Financial Results

Go back to NewLink Genetics Reports Second Quarter 2016 Financial Results

NewLink Genetics (NLNK) Misses Q2 EPS by 35c; Announces Restructuring Plans

July 29, 2016 8:09 AM EDT

NewLink Genetics (NASDAQ: NLNK) reported Q2 EPS of ($1.12), $0.35 worse than the analyst estimate of ($0.77).

Restructuring

The company also announced that it has... More